Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(137 intermediate revisions by 6 users not shown)
Line 3: Line 3:
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!Notes
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
|
|-
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans+Jack Reid+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|
|
|
|
Line 29: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 36: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|FQR
|
|
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
|(trainee), Daynna J.Wolff
|
|
|
|pending faculty review
|
|FQR
|
|
|
|
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans+ Fabiola Quintero-Rivera
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 75: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|FQR
|FQR
|
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|FQR
|
|
|
|
|complete
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|FQR
|Complete
|Complete
|
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu+Fabiola Quintero-Rivera
|    Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|Complete
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|
|
|FQR
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
|Complete
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|PENDING
|
|
|Complete
|
|
|FQR
|
|NON-WHO ENTITY
|-
|-
|    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
|    Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
| || || ||
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|
|9/1/20
|PENDING
|
|FQR
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Jennelle Hodge (JH)
|Complete
|
|
|
|
|-
|complete
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
|
|Complete
|FQR
|
|
|
|
|-
|-
|    Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|PENDING
|
|
|
|complete
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|PENDING
|
|
|9/1/20
|pending
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
|Complete
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|JH
|Complete
|
|
|
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|9/1/20
|PENDING
|
|
|Need permission for figure?  Update WHO?
|FQR
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
|Complete
|Complete
|
|
|Add WHO reference
|FQR
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|complete
|
|
|-
|FQR
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
|Complete
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|PENDING
|
|FQR
|
|
|
|
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
| || ||
|Complete
|
|
|
|
|
|-
| ||
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
|Complete
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
|Complete
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|Complete
|
|
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
|Complete
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS
|
|
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH
|    Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou
|Complete
|
|
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
|Complete
|Complete
|
| ||JH / MS
|03/02/2021-MS (re-review)
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|Complete
|
|
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
|Complete
|Complete
|
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|PENDING
|
|
|
|
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
|Complete
|
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|PENDING
|
|
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|??
|
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH
|    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|??
|
|
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng  Choy via Greg Conboy (Monash Health)
|JH
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|Disease
|
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|Complete
|-
| ||JH / MS
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|02/24/2021-MS (re-review)
|Disease
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
| || || ||
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?  Update WHO?
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Add WHO reference
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|YA
|PENDING
|
|
|
|
|-
|Complete
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
| ||JH / MS
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 
|
Lisa Smith + Yassmine Akkari
|
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|
|
|Complete
| ||JH / MS
|
|
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Helene Bruyere
|YA
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
| || || ||
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|SP
|
|
|
|
|Malini to review
|Complete
| ||JH / MS
|
|Need permission for figure?
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|SP
|
|
|
|
|Malini to review
|Complete
|-
| ||JH / MS
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|SP
|
|
|
|
|Malini to review
|-
|-
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|    Myeloid Leukemia Associated with Down Syndrome||Disease||Linda Cooley
|SP
|
|
|
|
|Malini to review
|Complete
|-
| ||JH / MS
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|SP
|
|
|
|
|Malini to review
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Gamma Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|SP
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|SP
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|SP
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|Acute Myeloid Leukemia (AML) with NUP214-ABL1
|SP
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|SP
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
| || ||
|
|
|
|
|
|
|-
| ||
|           Primary  Amyloidosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||Yassmine Akkari (YA)
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||YA
|         TEMPI Syndrome||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|
|
|PENDING
|
|
|-
|YA
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|-
|Follicular Lymphoma||Disease|| ||SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Testicular Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Follicular Neoplasia||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|
|
|Complete
|
|
|-
|YA
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|
|
|Complete
|
|
|-
|YA
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
|    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel
|SP
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
| || || ||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
|-
|YA
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|-
|PENDING
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|
|
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
| || ||
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|
|
| ||
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||Snehal Patel (SP)
|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC
|completed
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease|| ||GC
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|   Multicentric Castleman Disease||Disease|| ||GC
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
| || || ||
|
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
|
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
|
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease|| ||SP
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||SP
|
|
|SP
|
|
|
|
|-
|-
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| ||SP
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
|
|
|SP
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|
|
|-
| ||SP
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
|
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||SP
|    Mu Heavy Chain  Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|SP
|
|
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|    Alpha Heavy Chain Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||SP
|
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease|| ||SP
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
|-
|SP
|Sézary Syndrome||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|
|
|PENDING
|
|
|-
|SP
|    Lymphomatoid  Papulosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease|| ||SP
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease|| ||SP
|           Primary  Amyloidosis||Disease||
|
|
|
|
|
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||SP
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||SP
|    Follicular T-cell  Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
|         POEMS Syndrome||Disease||
|
|
|
|
|
|
|-
| ||SP
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|SP
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|         TEMPI Syndrome||Disease||
|SP
|
|
|
|
|
|
|-
| ||SP
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|SP
|
|
|
|
|
|-
|-
| || || ||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease|| ||
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|-
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease|| ||
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|
|
|
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease|| ||
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||''Anna Shestakova,''
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|
|
|-
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Multicentric Castleman  Disease||Disease||
|
|
|
| ||GC
|
|
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
|
|
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
| ||GC
|
|
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Aggressive NK-cell Leukemia||Disease||
|
|
|
| ||SP
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Lymphomatoid  Papulosis||Disease||
|
|
|
| ||SP
|
|
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''


Fabiola Quintero-Rivera
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
Line 1,165: Line 2,416:
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|MECOM
|Brian Davis
|
|
|
|
|Pending
|
|
|-
|          Monomorphic  B-cell PTLD||Disease|| ||
|
|
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|FGFR1(FLT2)
|Brian Davis
|
|
|
|
|Pending
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|KMT2A
|
|
|
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|DEK
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease|| ||
|
|
|
|
|
|
|-
|-
|   Langerhans Cell  Sarcoma||Disease|| ||
|NUP214
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|
|
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|RBM15
|
|
|
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|MKL1
|
|
|
|
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease|| ||
|
|
|
|
|
|
|-
|-
| || || ||
|DDX41
|Ying Zou
|8/7/20
|
|
|Pending
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|ANKRD26
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|CUX1
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|TET2
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|EZH2
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|FOXP1
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|MYC
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
|'''Gene'''
|'''Author'''
|'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,374: Line 2,566:
|
|
|-
|-
|WT1
|DONE
|
|
|
|
|DONE
|
|
|
|
Line 1,381: Line 2,576:
|
|
|-
|-
|CBL
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,395: Line 2,586:
|
|
|-
|-
|NF1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,409: Line 2,596:
|
|
|-
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,423: Line 2,606:
|
|
|-
|-
|ERG
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,437: Line 2,616:
|
|
|-
|-
|EST2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,451: Line 2,626:
|
|
|-
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,465: Line 2,636:
|
|
|-
|-
|RB1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,479: Line 2,646:
|
|
|-
|-
|MPL
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,493: Line 2,656:
|
|
|-
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,507: Line 2,666:
|
|
|-
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,521: Line 2,676:
|
|
|-
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,535: Line 2,686:
|
|
|-
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,549: Line 2,696:
|
|
|-
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,563: Line 2,706:
|
|
|-
|-
|ASXL1
|DONE
|
|
|
|
|DONE
|
|
|
|
Line 1,570: Line 2,716:
|
|
|-
|-
|MN1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,584: Line 2,726:
|
|
|-
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,598: Line 2,736:
|
|
|-
|-
|EP300
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,612: Line 2,746:
|
|
|-
|-
|JARID2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,626: Line 2,756:
|
|
|-
|-
|BRCA1
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,640: Line 2,766:
|
|
|-
|-
|BRCA2
|
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,657: Line 2,779:
|
|
|
|
|
|
|
|-
|
|
|
|
Line 1,671: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"